circ_0008882通过海绵吸附miR-155-5p上调PDE7A抑制脓毒症急性肾损伤进展
该研究以脂多糖(LPS)刺激人肾小管上皮细胞(HK2)建立脓毒症急性肾损伤(AKI)细胞模型,检测circ_0008882、miR-155-5p与磷酸二酯酶7A(PDE7A)的表达及细胞活力、炎症因子、细胞周期与凋亡。结果显示脓毒症AKI血清样本和LPS诱导的HK2细胞中circ_0008882与PDE7A低表达、miR-155-5p高表达;过表达circ_0008882可减轻LPS诱导的HK2细胞损伤,miR-155-5p模拟物可逆转该效应,PDE7A下调几乎逆转miR-155-5p抑制剂带来的改善。双荧光素酶报告基因与RNA免疫沉淀实验验证了circ_0008882靶向miR-155-5p、miR-155-5p靶向PDE7A的分子关系。作者认为circ_0008882可能成为脓毒症AKI的circRNA靶向治疗方向。
要点
- 脓毒症AKI血清样本与LPS诱导的HK2细胞均表现为circ_0008882、PDE7A低表达、miR-155-5p高表达(与对照相比)。
- 过表达circ_0008882可减轻LPS诱导的HK2细胞损伤。
- miR-155-5p是circ_0008882的靶点,miR-155-5p模拟物可逆转circ_0008882过表达对LPS处理HK2细胞的效应。
- PDE7A是miR-155-5p的靶基因,PDE7A下调几乎逆转miR-155-5p抑制剂带来的改善作用。
- 作者认为circ_0008882可能成为脓毒症AKI的circRNA靶向治疗方向。
适用人群与场景
- 脓毒症急性肾损伤(AKI)患者血清样本及脂多糖(LPS)刺激的人肾小管上皮细胞(HK2)脓毒症AKI细胞模型。
研究设计与关键结果
- 研究类型为细胞实验:以LPS刺激HK2细胞建立脓毒症AKI细胞模型,并以脓毒症AKI血清样本与对照比较。
- 脓毒症AKI血清样本和LPS诱导的HK2细胞较对照显示circ_0008882与PDE7A低表达、miR-155-5p高表达。
- 过表达circ_0008882可减轻LPS诱导的HK2细胞损伤。
- 双荧光素酶报告基因与RNA免疫沉淀实验证实miR-155-5p为circ_0008882的靶点;miR-155-5p模拟物可逆转circ_0008882过表达介导的对LPS处理HK2细胞的效应。
- PDE7A被鉴定为miR-155-5p的靶基因;PDE7A下调几乎逆转miR-155-5p抑制剂诱导的改善作用。
- 检测指标包括circ_0008882、miR-155-5p、PDE7A、PCNA、Bax、Bcl-2的RNA与蛋白表达,细胞活力(CCK-8法),炎症因子TNF-α、IL-1β、IL-6(ELISA法),细胞周期与凋亡(流式细胞术)及Caspase3活性(Caspase3检测试剂盒)。
证据类型、等级与局限
- 证据类型:细胞实验(体外研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,circ_0008882可能成为脓毒症AKI的circRNA靶向治疗方向。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: The importance of circular RNA (circRNA) in the progression of septic acute kidney injury (AKI) was gradually recognized. It has been confirmed that circ_0008882 expression was decreased in the blood of patients with AKI. However, the role of circ_0008882 in septic AKI progression remains unclear. Methods: Human kidney-2 (HK2) cells were stimulated with lipopolysaccharide (LPS) to establish a septic AKI cell model. The RNA and protein expression of circ_0008882, miR-155-5p, phosphodiesterase 7A (PDE7A), PCNA, Bax, and Bcl-2 were detected by quantitative real-time polymerase chain reaction and Western blot. Cell viability was investigated by cell counting kit-8 assay. Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the levels of inflammatory factors (TNF-α, IL-1β, and IL-6). Flow cytometry was implemented to evaluate cell cycle and cell apoptosis. The Caspase3 activity was examined using Caspase3 Assay Kit. Dual-luciferase reporter assay and RNA immunoprecipitation assay were applied to verify the molecular target relations. Results: Septic AKI serum samples and LPS-induced HK2 cells displayed low expression of circ_0008882 and PDE7A, and high expression of miR-155-5p when compared with the controls. Overexpression of circ_0008882 relieved LPS-induced HK2 cell injury. MiR-155-5p was a target of circ_0008882, and miR-155-5p mimic restored circ_0008882 overexpression-mediated effects on LPS-treated HK2 cells. PDE7A was identified as a target gene of miR-155-5p, and PDE7A downregulation almost reverted the improvement impacts induced by the miR-155-5p inhibitor. Conclusions: Overexpression of circ_0008882 impeded LPS-induced HK2 cell injury by modulating miR-155-5p/PDE7A pathway, implying that circ_0008882 might be a possible circRNA-targeted therapy for septic AKI.
参考来源
- You T, Kuang F. CIRC_0008882 STIMULATES PDE7A TO SUPPRESS SEPTIC ACUTE KIDNEY INJURY PROGRESSION BY SPONGING MIR-155-5P. Shock. 2023. PMID: 36772990. doi:10.1097/SHK.0000000000002093
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。